Derivation of Naïve Human Embryonic Stem Cells Using a CHK1 Inhibitor
-
Published:2023-09-13
Issue:8
Volume:19
Page:2980-2990
-
ISSN:2629-3269
-
Container-title:Stem Cell Reviews and Reports
-
language:en
-
Short-container-title:Stem Cell Rev and Rep
Author:
Ware Carol B., Jonlin Erica C., Anderson Donovan J., Cavanaugh Christopher, Hesson Jennifer, Sidhu Sonia, Cook Savannah, Villagomez-Olea Guillermo, Horwitz Marshall S., Wang Yuliang, Mathieu JulieORCID
Abstract
AbstractEmbryonic development is a continuum in vivo. Transcriptional analysis can separate established human embryonic stem cells (hESC) into at least four distinct developmental pluripotent stages, two naïve and two primed, early and late relative to the intact epiblast. In this study we primarily show that exposure of frozen human blastocysts to an inhibitor of checkpoint kinase 1 (CHK1) upon thaw greatly enhances establishment of karyotypically normal late naïve hESC cultures. These late naïve cells are plastic and can be toggled back to early naïve and forward to early primed pluripotent stages. The early primed cells are transcriptionally equivalent to the post inner cell mass intermediate (PICMI) stage seen one day following transfer of human blastocysts into in vitro culture and are stable at an earlier stage than conventional primed hESC.
Graphical Abstract
Funder
ISCRM private funds
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Hough, S. R., Laslett, A. L., Grimmond, S. B., Kolle, G., & Pera, M. F. (2009). A continuum of cell states spans pluripotency and lineage commitment in human embryonic stem cells. PLoS One, 4(11), e7708. https://doi.org/10.1371/journal.pone.0007708 2. Moody, J. D., Levy, S., Mathieu, J., Xing, Y., Kim, W., Dong, C., Tempel, W., Robitaille, A. M., Dang, L. T., Ferreccio, A., Detraux, D., Sidhu, S., Zhu, L., Carter, L., Xu, C., Valensisi, C., Wang, Y., Hawkins, R. D., Min, J., … Ruohola-Baker, H. (2017). First critical repressive H3K27me3 marks in embryonic stem cells identified using designed protein inhibitor. Proceedings of the National Academy of Sciences, 114(38), 10125–10130. https://doi.org/10.1073/pnas.1706907114 3. Mathieu, J., Detraux, D., Kuppers, D., Wang, Y., Cavanaugh, C., Sidhu, S., Levy, S., Robitaille, A. M., Ferreccio, A., Bottorff, A., McAlister, L., Somasundaram, L., Artoni, F., Battle, S., Hawkins, R. D., Moon, R. T., Ware, C. D., Paddison, P. J., & Ruohola-Baker, H. (2019). Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency. Nature Communications, 10(1), 632. https://doi.org/10.1038/s41467-018-08020-0 4. Morgani, S., Nichols, J., & Hadjantonakis, A. K. (2017). The many faces of Pluripotency: In vitro adaptations of a continuum of in vivo states. BMC Developmental Biology, 17(1), 7. https://doi.org/10.1186/s12861-017-0150-4 5. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P., Sun, B., de Sousa, C., Lopes, S. M., Howlett, S. K., Clarkson, A., Ahrlund-Richter, L., Pedersen, R. A., & Vallier, L. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448(7150), 191–195. https://doi.org/10.1038/nature05950
|
|